Abstract
Primary peritoneal mesothelioma (PM) is a rare and aggressive malignancy that arises from the peritoneum and classified into diffuse malignant peritoneum mesothelioma (DMPM) and borderline variants, viz. multicystic peritoneal mesothelioma (MCPM) and well-differentiated papillary peritoneal mesothelioma (WDPPM). The borderline variants are rarer than conventional DMPM, are less aggressive form accounting for 3–5% of all cases of peritoneal mesothelioma. In this narrative review article, we have discussed the pathogenesis, clinical presentation, natural history, and management of these rarer variants of PM, viz. MCPM and WDPPM. Histologically, MCPM typically consists of small cysts composed of mesothelial epithelium with benign bland cuboidal cells with clear fluids; cells lack cellular atypia and have increased number of mitoses. WDPPM has specific papillary component with myxoid plump cores and single layer of bland mesothelial cells. Both the variants commonly present as incidental finding or symptoms of chronic abdominal pain, chronic pelvic inflammatory disease, pelvic mass, and infertility. In the absence of treatment, these diseases are slow growing with major concerns being that both the variants have malignant transformation capabilities and a high rate of recurrence. In the light of current evidences, it is recommended that MCPM and WDPPM patients should be offered a complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy consisting of cisplatin and doxorubicin. Collaborative multi-institutional studies are needed to generate more data and formulate robust guidelines.
Similar content being viewed by others
References
Moolgavkar SH, Meza R, Turim J (2009 Aug) Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes Control CCC 20(6):935–944
Zhang CH, Yu JW, Luo M (2017) Multicystic peritoneal mesothelioma: a short review. Curr Probl Cancer 41(5):340–348
Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M (2007) Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol 14(10):2790–2797
Baratti D, Vaira M, Kusamura S, D’Amico S, Balestra MR, Cioppa T et al (2010) Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Eur J Surg Oncol EJSO 36(11):1047–1053
Kusamura S, Kepenekian V, Villeneuve L, Lurvink RJ, Govaerts K, De Hingh IHJT et al (2021) Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 47(1):36–59
Kannerstein M, Churg J (1977) Peritoneal mesothelioma. Hum Pathol 8(1):83–94
Attanoos RL, Gibbs AR (1997) Pathology of malignant mesothelioma. Histopathology 30(5):403–418
Weiss SW, Tavassoli FA, Multicystic mesothelioma. (1988) An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 12(10):737–746
Kurisu Y, Tsuji M, Shibayama Y, Yamada T, Ohmichi M (2011) Multicystic mesothelioma caused by endometriosis: 2 case reports and review of the literature. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol 30(2):163–166
Malpica A, Sant’ Ambrogio S, Deavers MT, Silva EG (2012 Jan) Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol 36(1):117–127
Ross MJ, Welch WR, Scully RE (1989) Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer 64(6):1336–1346
Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Sallé F, Hwang H et al (2014) Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol 38(7):990–998
Daya D, McCaughey WT (1990) Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 65(2):292–296
Chen X, Sheng W, Wang J (2013) Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology 62(5):805–813
Lee YK, Jun HJ, Nahm JH, Lim TS, Park JS, Ahn JB et al (2013) Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. Jpn J Clin Oncol 43(10):996–1003
Nizri E, Baratti D, Guaglio M, Sinukumar S, Cabras A, Kusamura S, Deraco M (2018) Multicystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy. Eur J Surg Oncol 44(7):1100–1104
Huang Y, Alzahrani NA, Liauw W, Morris DL (2015) Effects of sex hormones on survival of peritoneal mesothelioma. World J Surg Oncol 26(13):210
van Ruth S, Bronkhorst MW, van Coevorden F, Zoetmulder FA (2002) Peritoneal benign cystic mesothelioma: a case report and review of the literature. Eur J Surg Oncol 28(2):192–195
Goldblum J, Hart WR (1995) Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 19(10):1124–1137
Torii I, Hashimoto M, Terada T, Kondo N, Fushimi H, Shimazu K et al (2010) Well-differentiated papillary mesothelioma with invasion to the chest wall. Lung Cancer Amst Neth 67(2):244–247
Costanzo L, Scarlata S, Perrone G, Rossi L, Papa A, Di Matteo FM et al (2014) Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report. Clin Respir J 8(1):124–129
Bürrig KF, Pfitzer P, Hort W (1990) Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol 417(5):443–447
Butnor KJ, Sporn TA, Hammar SP, Roggli VL (2001) Well-differentiated papillary mesothelioma. Am J Surg Pathol 25(10):1304–1309
Gilani SNS, Mehta A, Garcia-Fadrique A, Rowaiye B, Jenei V, Dayal S et al (2018) Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival. Int J Hyperth 34(5):578–584
Mehta V, Chowdhary V, Sharma R, Golia Pernicka JS (2017) Imaging appearance of benign multicystic peritoneal mesothelioma: a case report and review of the literature. Clin Imaging 42:133–137
Safioleas MC (2006) Benign multicystic peritoneal mesothelioma: a case report and review of the literature. World J Gastroenterol 12(35):5739
Noiret B, Renaud F, Piessen G, Eveno C (2019) Multicystic peritoneal mesothelioma: a systematic review of the literature. Pleura Peritoneum 4(3) https://www.degruyter.com/document/doi/10.1515/pp-2019-0024/html. Accessed 25 Sep 2019
Vicens RA, Patnana M, Le O, Bhosale PR, Sagebiel TL, Menias CO et al (2015) Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists. Abdom Imaging 40(2):436–456
Bazine A, Fetohi M, Namad T, Benzekri A, Zainoun B, Tanz R et al (2017) A case of well-differentiated papillary mesothelioma of the male peritoneum: successful treatment by systemic chemotherapy. Cureus 9(3). http://www.cureus.com/articles/6239-a-case-of-well-differentiated-papillary-mesothelioma-of-the-male-peritoneum-successful-treatment-by-systemic-chemotherapy. Accessed 19 Mar 2017
Lee HE, Molina JR, Sukov WR, Roden AC, Yi ES (2018) BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma. Hum Pathol 79:168–176
Sethna K, Mohamed F, Marchettini P, Elias D, Sugarbaker PH (2003) Peritoneal cystic mesothelioma: a case series. Tumori J 89(1):31–35
Chua TC, Yan TD, Deraco M, Glehen O, Moran BJ, Sugarbaker PH (2010) Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. Br J Surg 98(1):60–64
Zahid A, Clarke L, Carr N, Chandrakumaran K, Tzivanakis A, Dayal S et al (2021) Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 5(2):zraa001
Yano H, Moran BJ, Cecil TD, Murphy EM (2009) Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol EJSO 35(9):980–985
Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN et al (2006) Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13(3):405–412
Kelarji AB, Alshutaihi MS, Ghazal A, Mahli N, Agha S (2021) A rare case of benign multicystic peritoneal mesothelioma misdiagnosed as hydatid cyst found in the liver parenchyma and abdomen cavity of a male with asbestos exposure. BMC Gastroenterol 21(1):374
Evangelopoulou EA, Zacharis K, Skoufi G, Vlassis N, Roidoula P, Lialios G (2021) Benign multicystic peritoneal mesothelioma in a postmenopausal woman complicated with an ovarian cyst: a case report. Pan Afr Med J 40:171
Mino JS, Monteiro R, Pigalarga R, Varghese S, Guisto L, Rezac C (2014) Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature. BMJ Case Rep 2014:bcr2013200212
Oshikiri H, Ozawa Y, Suzuki O, Usuda M, Miyata G (2022) Benign multicystic peritoneal mesothelioma occurring in bilateral inguinal canals metachronously: a case report. Surg Case Rep 8(1):44
Dzieniecka M, Kałużyński A (2011) Benign multicystic peritoneal mesothelioma (BMPM) - case report and review of the literature. Pol J Pathol Off J Pol Soc Pathol 62(2):122–124
Hamza A, Zazo A, Alrifai MK, Khoja S, Shebli B, Fattal F et al (2021) Benign multicystic peritoneal mesothelioma (BMPM) presenting with ambiguous symptoms: a rare case report. Ann Med Surg 61:85–87
Luna-Abanto J, Mendoza-Tisoc G, Huanca-Amesquita L, Berrospi-Espinoza F (2020) Benign multicystic peritoneal mesothelioma in a male teen: case report and review of the literature. P R Health Sci J 39(2):222–225
Alvir I, Bevanda B, Danolić D, Mamić I, Kostić L, Starčević-Božović A, Puljiz M (2021) Benign multicystic peritoneal mesothelioma mimicking gynecologic pathology. Acta Clin Croat 60(2). https://pubmed.ncbi.nlm.nih.gov/34744286/. Accessed 6 Oct 2017
Jeong JY, Kim SH (2001) Sclerotherapy of peritoneal inclusion cysts: preliminary results in seven patients. Korean J Radiol 2(3):164
Letterie GS, Yon JL (1998) The antiestrogen tamoxifen in the treatment of recurrent benign cystic mesothelioma. Gynecol Oncol 70(1):131–133
Passot G, Bakrin N, Isaac S, Decullier E, Gilly FN, Glehen O et al (2014) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol EJSO 40(8):957–962
Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J (2018) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience. World J Surg 42(10):3120–3124
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Proof of Consent
Since the given manuscript is a literature review, none of the patients’ identification has been revealed and hence not applicable for this manuscript.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chatterjee, A., Bhatt, A. Rare Variants of Malignant Peritoneal Mesothelioma: a Literature Review. Indian J Surg Oncol 14 (Suppl 1), 30–38 (2023). https://doi.org/10.1007/s13193-023-01754-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-023-01754-4